Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/26 20:17 | 9/16/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Lo Francis | WA | O | Chief Pe | 3 | S.dm | -7,785 | 24.56 | 0 | -317 | 233 | D | |||||||||||||||
9/17/26 18:50 | 9/15/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Bobulsky Susan | WA | O | Chief Co | 5 | S | -264 | 24.06 | 0 | -11 | 406 | D | |||||||||||||||
8/28/26 17:50 | 8/26/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Owen Katey Einterz | WA | D | 1 | S | -250 | 26.00 | 0 | -10 | 79 | D | ||||||||||||||||
8/20/26 17:55 | 8/18/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Hershberg Robert | WA | D | 1 | S.d | -748 | 24.40 | 0 | -31 | 47 | D | ||||||||||||||||
8/19/26 20:15 | 8/17/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Robins Chad M | WA | DO | CEO,CB | 1 | S.dm | -14,882 | 24.80 | 0 | -600 | 2,181 | D | |||||||||||||||
8/19/26 20:07 | 8/17/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Neupert Peter M | WA | D | 1 | S.d | -3,136 | 25.15 | 0 | -125 | 131 | D | ||||||||||||||||
7/23/26 19:34 | 7/21/26 | ADPT | Health | BioPrd | Biological Products, (No Diag | Robins Harlan S | WA | O | Chief Sc | 2 | S.d | -19,282 | 21.94 | 0 | -879 | 1,020 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |